Health charities team up for cancer care
The Bermuda Cancer and Health Centre has announced a memorandum of understanding with the cancer charity and longstanding partner organisation Pals, reflecting their “shared commitment to delivering co-ordinated, patient-centred cancer care and support across Bermuda”.
The agreement was jointly signed by Chris Fosker, the chief executive and medical director of the BCHC, and Colleen English, the executive director of Pals.
Across their history, the two charities have focused on different stages of the cancer care pathway to avoid duplication of services.
The BCHC provides cancer prevention education, genetic counselling and testing, cancer navigation, breast screening, diagnostic imaging and oncology services, including the island’s only radiation therapy unit.
Pals offers home-based cancer care and support during and after treatment, with services including nursing care, emotional support, practical assistance, essential equipment and transportation.
The two organisations said that strengthening their collaboration would offer greater stability, continuity and reassurance.
The agreement also means the two will work more closely across several areas, including co-ordinated patient care, wellness and survivorship support, shared educational initiatives, and the development of new or enhanced support services.
Dr Fosker said the agreement “formalises what has long been true, that Pals and BCHC share a deep commitment to providing compassionate, integrated care for our community”.
Ms English said: “For 45 years, Pals has supported Bermuda’s cancer patients, providing compassionate care where it matters most — at home.
“Strengthening our partnership with Bermuda Cancer and Health Centre ensures every patient receives seamless, co-ordinated care, guided by dignity, respect and compassion, from diagnosis through treatment and home-based support.”
The agreement includes opportunities for shared staff training, collaborative service improvements, co-branded community education, and joint evaluation of patient experience and outcomes.
A joint liaison group is to meet regularly to guide the partnership, monitor progress and identify areas for innovation.
